Abstract
Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have